Cita APA

Cortellini, A., Brunetti, L., Di Fazio, G., Garbo, E., Pinato, D. J., Naidoo, J., . . . Ricciuti, B. (2025). Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials.

Citación estilo Chicago

Cortellini, Alessio|||0000-0002-1209-5735, et al. Determinants of 5-year Survival in Patients With Advanced NSCLC With PD-L1≥50% Treated With First-line Pembrolizumab Outside of Clinical Trials. 2025.

Cita MLA

Cortellini, Alessio|||0000-0002-1209-5735, et al. Determinants of 5-year Survival in Patients With Advanced NSCLC With PD-L1≥50% Treated With First-line Pembrolizumab Outside of Clinical Trials. 2025.